for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Antibe Therapeutics receives approval to initiate phase 2 gastrointestinal endoscopy clinical trial

Aug 2 (Reuters) - Antibe Therapeutics Inc

* Antibe Therapeutics receives approval to initiate phase 2 gastrointestinal endoscopy clinical trial

* Antibe Therapeutics Inc - it is anticipated that study will be completed in early 2018 for

* Antibe Therapeutics Inc - study is expected to begin immediately, and will be performed by Topstone Research, in Toronto Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up